News for GlaxoSmithKline plc (GS7.F)

The U.S. death toll from the coronavirus-borne illness COVID-19 climbed above 520,000 on Friday, as Dr. Anthony Fauci became the latest health expert to slam...

The Swiss drug company will make mRNA and other parts of CureVac’s two-dose vaccine, which is in late-stage testing with results expected as soon as next month.

Today's Daily Dose brings you news about KemPharm scoring regulatory nod for its ADHD drug, expanded FDA approval for Pfizer's Lorbrena, United Therapeutics scrapping the development of Trevyent, Vir Biotechnology closing the enrollment in VIR-7831 arm of ACTIV-3 trial, and Takeda securing global rights to Ovid's investigational medicine Soticlestat.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Shares of Vir Biotechnology Inc. (VIR) are losing nearly 30% on Wednesday morning after the company said it has stopped enrollment in COVID-19 vaccine trial. VIR is currently trading at $41.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) ...

ALBANY, N.Y., March 2, 2021 /PRNewswire/ -- The benefits of consuming calcium on bone mass and facilitating general bone health in adolescents and...

- Rise in demand for effervescent supplements and high-value mineral salts propelling attention on calcium malate supplements among populations- P...

/PRNewswire/ -- The benefits of consuming calcium on bone mass and facilitating general bone health in adolescents and adults have been scientifically...

Texas, March 02, 2021 (GLOBE NEWSWIRE) -- The growth of this market is primarily due to the high prevalence of infectious diseases, increased government ...

Peptide Therapeutics Market Set for Linear Growth at 11% CAGR through 2030; Market to Witness Decline in Near Term Due to COVID-19 Pandemic

According to a Healthcare Expert at Future Market Insights, “Factors such as growing prevalence of chronic diseases in dogs, rising pets adoption, increased

SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new...

Generic injectable drugs are those which have same active ingredient as innovator drug and is equivalent to its innovator drug in dosage form, safety,

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Live Vaccines Market.

Pune, India, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Nutraceuticals Market Overview: As per the assessment by Market Research Future (MRFR), the Nutraceuticals ...

Pune, India, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Toothpaste Market Overview: Market Research Future (MRFR) studied the Global Toothpaste Market 2020 through ...

According to a latest research by Future Market Insights (FMI), the global dental hygiene devices market is projected to account for over US$ 5,875.0 Mn in

Pune, Feb. 24, 2021 (GLOBE NEWSWIRE) -- According to Fortune Business Insights™, the global sports drink market size is expected to reach $32.61 ...